Cellular Reprogramming and Metastatic Disease

Cellular Reprogramming and Metastatic Disease aims to explore current understanding of the molecular mechanisms that allow cancer cells to leave the primary site, disseminate, and grow as metastatic disease in
a foreign tissue. The Conference will also explore how these cells avoid/resist treatment as part of such metastatic disease progression. Despite major advances in cancer treatment, once tumors metastasize, and regardless of the tumor type, prognosis remains dismal. New knowledge suggest that beyond genetic mutations, cancers cells may acquire non-genetic adaptations that could confer unique advantage to these aggressive cells.